These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 32654006)

  • 1. Emerging pharmacological therapies for ARDS: COVID-19 and beyond.
    Horie S; McNicholas B; Rezoagli E; Pham T; Curley G; McAuley D; O'Kane C; Nichol A; Dos Santos C; Rocco PRM; Bellani G; Laffey JG
    Intensive Care Med; 2020 Dec; 46(12):2265-2283. PubMed ID: 32654006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging cellular and pharmacologic therapies for acute respiratory distress syndrome.
    Gonzalez H; Horie S; Laffey JG
    Curr Opin Crit Care; 2021 Feb; 27(1):20-28. PubMed ID: 33278121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-Associated acute respiratory distress syndrome (CARDS): Mechanistic insights on therapeutic intervention and emerging trends.
    Thapa K; Verma N; Singh TG; Kaur Grewal A; Kanojia N; Rani L
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108328. PubMed ID: 34768236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

  • 5. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
    Qin H; Zhao A
    Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury.
    Cattel F; Giordano S; Bertiond C; Lupia T; Corcione S; Scaldaferri M; Angelone L; De Rosa FG
    Respir Physiol Neurobiol; 2021 Jun; 288():103645. PubMed ID: 33657448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches.
    Bosma KJ; Taneja R; Lewis JF
    Drugs; 2010 Jul; 70(10):1255-82. PubMed ID: 20568833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-based therapies for the acute respiratory distress syndrome.
    Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic Treatments in Acute Respiratory Failure.
    Levy E; Reilly JP
    Crit Care Clin; 2024 Apr; 40(2):275-289. PubMed ID: 38432696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for treating the acute respiratory distress syndrome.
    Shaw TD; McAuley DF; O'Kane CM
    Expert Opin Emerg Drugs; 2019 Mar; 24(1):29-41. PubMed ID: 30841764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
    Khiali S; Khani E; Entezari-Maleki T
    J Clin Pharmacol; 2020 Sep; 60(9):1131-1146. PubMed ID: 32557541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of MicroRNAs in Acute Respiratory Distress Syndrome and Sepsis, From Targets to Therapies: A Narrative Review.
    Lee LK; Medzikovic L; Eghbali M; Eltzschig HK; Yuan X
    Anesth Analg; 2020 Nov; 131(5):1471-1484. PubMed ID: 33079870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review.
    Ragel EJ; Harris LK; Campbell RA
    BMJ Open Respir Res; 2023 Sep; 10(1):. PubMed ID: 37657844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19.
    Ball L; Silva PL; Giacobbe DR; Bassetti M; Zubieta-Calleja GR; Rocco PRM; Pelosi P
    Expert Rev Respir Med; 2022 Apr; 16(4):437-446. PubMed ID: 35341424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory therapies for acute respiratory distress syndrome.
    Battaglini D; Iavarone IG; Al-Husinat L; Ball L; Robba C; Silva PL; Cruz FF; Rocco PR
    Expert Opin Investig Drugs; 2023; 32(12):1143-1155. PubMed ID: 37996088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS).
    Huang Q; Le Y; Li S; Bian Y
    Respir Res; 2024 Jan; 25(1):30. PubMed ID: 38218783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
    Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
    Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
    Curley GF; O'Kane CM; McAuley DF; Matthay MA; Laffey JG
    Am J Respir Crit Care Med; 2024 Apr; 209(7):789-797. PubMed ID: 38324017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.